Elsevier

Biochemical Pharmacology

Volume 38, Issue 10, 15 May 1989, Pages 1657-1665
Biochemical Pharmacology

Comparative drug metabolism of diazepam in hepatocytes isolated from man, rat, monkey and dog

https://doi.org/10.1016/0006-2952(89)90314-6Get rights and content

Abstract

Diazepam (DZ) was used as a substrate in drug metabolism studies to characterise the differences in metabolite profiles in hepatocytes isolated from four species: Wistar rat, cynomolgus monkey, beagle dog and man. Hepatocytes were incubated with DZ (20 μM) for 180 min at 3 hr post isolation in culture, and the disappearance of parent compound and appearance of its metabolites determined. DZ disappearance was found to be monoexponential in rat, monkey and human cells, but that DZ disappearance in dog hepatocytes was best described by a two compartment process. There were considerable differences in both the rates of formation and the profiles of metabolites produced from DZ in each species. Drug metabolism of DZ was determined in five human hepatocyte preparations. The rates of formation of both the major metabolites, temezepam (TEM) and nordiazepam (NOR) were highly variable between samples, and oxazepam (OX) was detected in only three of the preparations. There was no evidence of further metabolism of these metabolites, and the profiles were comparable with in vivo findings. In a single case, human hepatocytes were cultured for five days, and DZ was used as substrate to characterise the changes in drug metabolising activities. There was a rapid loss in the production of OX in the initial 24 hr, and a complete loss of 3-hydroxylation activities in the succeeding 120 hr. N-demethylation activities, however, were well maintained, and the appearance of NOR declined to 47% of initial rate.

The hepatocytes of all species were found to produce NOR and TEM as metabolites; NOR representing the principal metabolite in the dog, monkey and human cells. In the dog, TEM was found only as a minor metabolite. OX was a significant metabolite in the monkey and a minor metabolite in the dog and human hepatocytes, but was not detected in rat cultures. The principal metabolite in rat cells was 4'-hydroxy diazepam, which was rapidly further metabolised to its glucuronide.

The drug metabolising activities of the hepatocyte cultures towards DZ were comparable with the drug metabolism of DZ found in vivo in each species. These findings substantiate hepatocytes as an in vitro model of hepatic metabolism.

References (27)

  • CA Green et al.

    Comparison of amphetamine metabolism using isolated hepatocytes from five species including human

    J Pharmacol Exp Ther

    (1985)
  • SJ Gee et al.

    Comparative metabolism of tolbutamide by isolated hepatocytes from rat, rabbit, dog and squirrel monkey

    Drug Metab Disp

    (1984)
  • U Klotz et al.

    Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat

    J Pharmacol Exp Ther

    (1976)
  • Cited by (66)

    • Tranquilizers, sedatives, local anaesthetics and antimuscarinic agents

      2023, Anesthesia and Analgesia in Laboratory Animals
    • Retrospective mass spectrometric analysis of wastewater-fed mesocosms to assess the degradation of drugs and their human metabolites

      2021, Journal of Hazardous Materials
      Citation Excerpt :

      Further compound that it falls in the Type-A is DZP with unchanged abundance between start and end samples (Fig. 3). The same wholes true for TMZ, NDZP and OZP (Seddon et al., 1989). While the two former compounds are known to be human metabolites originating from hydroxylation and N-demethylation respectively, OZP is both a prescription drug itself and the metabolite of diazepam as shown in Fig. 3.

    • Pharmacodynamic and pharmacokinetic interactions between simvastatin and diazepam in rats

      2017, Pharmacological Reports
      Citation Excerpt :

      In the liver diazepam is metabolized to three main active metabolites: desmethyldiazepam, oxazepam and temazepam. The metabolism of diazepam depends on the species, age, sex, presence of liver diseases, genetic variability and the exposure to inducers or inhibitors of cytochrome P450 (CYP450) [4]. The 3-hydroxy-3-methylglutaryl-coenzyme (HMG-CoA) reductase inhibitors, commonly known as statins, are the most potent and most widely used cholesterol lowering drugs.

    • Quantitative profiling of prostaglandins as oxidative stress biomarkers in vitro and in vivo by negative ion online solid phase extraction - Liquid chromatography-tandem mass spectrometry

      2016, Analytical Biochemistry
      Citation Excerpt :

      Ferric nitrilotriacetic acid [Fe(III)NTA] stock solution (20 mM) was prepared by mixing 5 ml of 0.1 M Fe(NO3)3 in 0.1 M HCl and 0.2 M NaNTA, filling up to 30 ml, and adjusting the pH to 7.4 with 1 M NaCO3. Primary cells were prepared freshly in-house by a two-step procedure for liver perfusion [27,28] and used in suspension. Incubation was performed at 37 °C in humidified atmosphere (5% CO2/95% air) in 96-well plates at a cell concentration of 1 million/ml and stopped after 1 or 3 h by precipitation with acetonitrile that contained the internal standard (PD2-d4 at a concentration of 1 ng/ml to reach a final concentration of 0.42 ng/ml).

    • Feline hepatic biotransformation of diazepam: Differences between cats and dogs

      2015, Research in Veterinary Science
      Citation Excerpt :

      All three metabolites are pharmacologically active. Nordiazepam appears to be the principal metabolite of diazepam in man and dogs, although species-specific differences in the relative quantities of these metabolites have been observed previously (Vree et al., 1979; Chenery et al., 1987; Seddon et al., 1989). The lipophilic metabolites temazepam and oxazepam are excreted as phase II glucuronides in the urine (Schwartz et al., 1965; Vree et al., 1979).

    • Pharmacology of Injectable Anesthetics, Sedatives, and Tranquilizers

      2008, Anesthesia and Analgesia in Laboratory Animals
    View all citing articles on Scopus
    View full text